{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T12:08:42Z","timestamp":1771416522103,"version":"3.50.1"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Department of Dermatology"},{"DOI":"10.13039\/100009736","name":"Voluntary Academic Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009736","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,18]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Many patients with melanoma experience worry, anxiety and distress. Screening for psychological distress can facilitate early identification and management. However, little is known about such distress in melanoma survivors and patients at high risk of developing melanoma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>The primary outcome was to assess the melanoma-related worry in melanoma survivors and patients at high risk of melanoma. Additionally, a secondary outcome was to determine the optimal Distress Thermometer (DT) cutoff for identifying those needing psycho-oncological support.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We prospectively collected the distress-related patient-reported outcomes at the Department of Dermatology of the University Hospital in Basel, Switzerland between January 2021 and January 2024. Validated questionnaires including the DT, Melanoma Worry Scale, Patient Health Questionnaire, and Generalized Anxiety Disorder were used to assess the primary outcome. For the secondary outcome, receiver operating characteristic (ROC) analysis was used to estimate the optimal DT cutoff.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The study population comprised 430 individuals, including 175 (41%) melanoma survivors and 255 (59%) patients at high risk for melanoma. Worry about getting a primary or subsequent melanoma was more prominent in melanoma survivors (26%) compared with patients at high risk for melanoma (16%). Patients at high risk for melanoma had less melanoma worry compared with melanoma survivors, with an odds ratio (OR) of 0.56 [95% confidence interval (CI) 0.34\u20130.93]. Melanoma worry predictors included being divorced (OR 3.08, 95% CI 1.28\u20137.38) and younger age (OR 0.97, 95% CI 0.95\u20130.99). Patients at high risk of melanoma showed significant higher distress [median DT 4, interquartile range (IQR) 2\u20136] compared with melanoma survivors (DT 2, IQR 1\u20135) (P &amp;lt; 0.001). ROC analysis estimated a DT score of 3 as the optimal cutoff for melanoma survivors, whereas a DT score of 6 was optimal in patients at high risk of melanoma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study found that melanoma survivors exhibit greater disease-specific worry, whereas patients at high risk for melanoma show increased general distress, underscoring their distinct psycho-oncological needs. Adopting tailored DT cutoffs (\u2265 3 for melanoma survivors, \u2265 6 for patients at high risk for melanoma) may improve the detection of clinically relevant distress. Importantly, interest in psychological support was observed across all DT scores, indicating the need for flexible, patient-centred approaches. These findings highlight the unmet need for psychosocial care in both melanoma survivors and patients at high risk of melanoma, and could aid dermatologists in screening patients for psychological distress.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/bjd\/ljaf439","type":"journal-article","created":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T00:10:11Z","timestamp":1762647011000},"page":"499-508","source":"Crossref","is-referenced-by-count":0,"title":["Psychological distress and unmet supportive care needs in melanoma survivors and patients at high risk of developing melanoma: a Swiss cross-sectional study"],"prefix":"10.1093","volume":"194","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8221-4760","authenticated-orcid":false,"given":"Johan","family":"Sieborg","sequence":"first","affiliation":[{"name":"Department of Dermatology, Copenhagen University Hospital \u2013 Bispebjerg and Frederiksberg , Copenhagen ,","place":["Denmark"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6300-3899","authenticated-orcid":false,"given":"Diana","family":"Zwahlen","sequence":"additional","affiliation":[{"name":"Department of Psychosomatics, University Hospital Basel , Basel ,","place":["Switzerland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9914-1545","authenticated-orcid":false,"given":"Julia-Tatjana","family":"Maul","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University Hospital Zurich , Zurich ,","place":["Switzerland"]},{"name":"Faculty of Medicine, University of Zurich , Zurich ,","place":["Switzerland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1250-2035","authenticated-orcid":false,"given":"Merete","family":"H\u00e6dersdal","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Copenhagen University Hospital \u2013 Bispebjerg and Frederiksberg , Copenhagen ,","place":["Denmark"]},{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences, University Copenhagen , Copenhagen ,","place":["Denmark"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7112-9387","authenticated-orcid":false,"given":"Emilie Westerlin","family":"Kjeldsen","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Copenhagen University Hospital \u2013 Bispebjerg and Frederiksberg , Copenhagen ,","place":["Denmark"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6488-0834","authenticated-orcid":false,"given":"Sara","family":"Cerminara","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University Hospital Basel , Basel ,","place":["Switzerland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9995-2912","authenticated-orcid":false,"given":"Elisabeth Victoria","family":"Goessinger","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University Hospital Basel , Basel ,","place":["Switzerland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8257-1816","authenticated-orcid":false,"given":"Alexander","family":"Egeberg","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Copenhagen University Hospital \u2013 Bispebjerg and Frederiksberg , Copenhagen ,","place":["Denmark"]},{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences, University Copenhagen , Copenhagen ,","place":["Denmark"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3962-7575","authenticated-orcid":false,"given":"Joanna","family":"Mangana","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University Hospital Zurich , Zurich ,","place":["Switzerland"]},{"name":"Faculty of Medicine, University of Zurich , Zurich ,","place":["Switzerland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7059-632X","authenticated-orcid":false,"given":"Alexander","family":"Navarini","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University Hospital Basel , Basel ,","place":["Switzerland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9202-0073","authenticated-orcid":false,"given":"Lara Valeska","family":"Maul","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University Hospital Zurich , Zurich ,","place":["Switzerland"]},{"name":"Faculty of Medicine, University of Zurich , Zurich ,","place":["Switzerland"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,11,5]]},"reference":[{"key":"2026021806304639900_ljaf439-B1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"2026021806304639900_ljaf439-B2","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/pon.1939","article-title":"Does screening for distress efficiently uncover meetable unmet needs in cancer patients?","volume":"20","author":"van Scheppingen","year":"2011","journal-title":"Psychooncology"},{"key":"2026021806304639900_ljaf439-B3","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1002\/pon.4735","article-title":"Focusing on cancer patients\u2019 intentions to use psychooncological support: a longitudinal, mixed-methods study","volume":"27","author":"Tondorf","year":"2018","journal-title":"Psychooncology"},{"key":"2026021806304639900_ljaf439-B4","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jad.2012.03.025","article-title":"Anxiety and depression after cancer diagnosis: prevalence rates by cancer type, gender, and age","volume":"141","author":"Linden","year":"2012","journal-title":"J Affect Disord"},{"issue":"Suppl. 6","key":"2026021806304639900_ljaf439-B5","first-page":"1","article-title":"Malignant melanoma S3-guideline \u2018diagnosis, therapy and follow-up of melanoma\u2019","volume":"11","author":"Pflugfelder","year":"2013","journal-title":"J Dtsch Dermatol Ges"},{"key":"2026021806304639900_ljaf439-B6","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1093\/annonc\/mdu366","article-title":"Prevalence and correlates of unmet supportive care needs in patients with resected invasive cutaneous melanoma","volume":"25","author":"Molassiotis","year":"2014","journal-title":"Ann Oncol"},{"key":"2026021806304639900_ljaf439-B7","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1001\/jamadermatol.2023.6158","article-title":"Lived experiences and fear of cancer recurrence among survivors of localized cutaneous melanoma","volume":"160","author":"Mahama","year":"2024","journal-title":"JAMA Dermatol"},{"key":"2026021806304639900_ljaf439-B8","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/CMR.0000000000000425","article-title":"Quality of life patient-reported outcomes for locally advanced cutaneous melanoma","volume":"28","author":"Weitman","year":"2018","journal-title":"Melanoma Res"},{"key":"2026021806304639900_ljaf439-B9","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1007\/s11136-020-02464-y","article-title":"Patient-reported outcomes in melanoma survivors at 1, 3 and 5\u2005years post-diagnosis: a population-based cross-sectional study","volume":"29","author":"Lisy","year":"2020","journal-title":"Qual Life Res"},{"key":"2026021806304639900_ljaf439-B10","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1054\/bjoc.2000.1471","article-title":"Psychosocial predictors of outcome: time to relapse and survival in patients with early stage melanoma","volume":"83","author":"Brown","year":"2000","journal-title":"Br J Cancer"},{"key":"2026021806304639900_ljaf439-B11","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1001\/archdermatol.2009.308","article-title":"Psychological responses and coping strategies among patients with malignant melanoma: a systematic review of the literature","volume":"145","author":"Kasparian","year":"2009","journal-title":"Arch Dermatol"},{"key":"2026021806304639900_ljaf439-B12","doi-asserted-by":"crossref","first-page":"e0132754","DOI":"10.1371\/journal.pone.0132754","article-title":"Psychosocial care needs of melanoma survivors: are they being met?","volume":"10","author":"Fischbeck","year":"2015","journal-title":"PLOS ONE"},{"key":"2026021806304639900_ljaf439-B13","doi-asserted-by":"crossref","first-page":"e7987","DOI":"10.1097\/MD.0000000000007987","article-title":"The need for psycho-oncological support for melanoma patients: central role of patients\u2019 self-evaluation","volume":"96","author":"Mayer","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"2026021806304639900_ljaf439-B14","doi-asserted-by":"crossref","first-page":"e0116440","DOI":"10.1371\/journal.pone.0116440","article-title":"Depression, anxiety and quality of life in long-term survivors of malignant melanoma: a register-based cohort study","volume":"10","author":"Beutel","year":"2015","journal-title":"PLOS ONE"},{"key":"2026021806304639900_ljaf439-B15","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/bjd\/ljae011","article-title":"Prevalence and odds of anxiety and depression in cutaneous malignant melanoma: a proportional meta-analysis and regression","volume":"191","author":"Kungwengwe","year":"2024","journal-title":"Br J Dermatol"},{"key":"2026021806304639900_ljaf439-B16","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1399-0004.2007.00949.x","article-title":"Predictors of psychological distress among individuals with a strong family history of malignant melanoma","volume":"73","author":"Kasparian","year":"2008","journal-title":"Clin Genet"},{"key":"2026021806304639900_ljaf439-B17","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1348\/014466501163904","article-title":"Normative data for the HADS from a large non-clinical sample","volume":"40","author":"Crawford","year":"2001","journal-title":"Br J Clin Psychol"},{"key":"2026021806304639900_ljaf439-B18","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1038\/s41436-021-01292-w","article-title":"Impact of personal genomic risk information on melanoma prevention behaviors and psychological outcomes: a randomized controlled trial","volume":"23","author":"Smit","year":"2021","journal-title":"Genet Med"},{"key":"2026021806304639900_ljaf439-B19","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1001\/jamadermatol.2014.2229","article-title":"Effects of total-body digital photography on cancer worry in patients with atypical mole syndrome","volume":"151","author":"Moye","year":"2015","journal-title":"JAMA Dermatol"},{"key":"2026021806304639900_ljaf439-B20","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jad.2008.06.026","article-title":"The PHQ-8 as a measure of current depression in the general population","volume":"114","author":"Kroenke","year":"2009","journal-title":"J Affect Disord"},{"key":"2026021806304639900_ljaf439-B21","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.genhosppsych.2015.11.005","article-title":"Screening for anxiety disorders with the GAD-7 and GAD-2: a systematic review and diagnostic metaanalysis","volume":"39","author":"Plummer","year":"2016","journal-title":"Gen Hosp Psychiatry"},{"key":"2026021806304639900_ljaf439-B22","doi-asserted-by":"crossref","first-page":"3750","DOI":"10.1002\/cncr.32981","article-title":"Validation of the 7-item Functional Assessment of Cancer Therapy-General (FACT-G7) as a short measure of quality of life in patients with advanced cancer","volume":"126","author":"Mah","year":"2020","journal-title":"Cancer"},{"key":"2026021806304639900_ljaf439-B23","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/pon.3430","article-title":"Validation of the distress thermometer worldwide: state of the science","volume":"23","author":"Donovan","year":"2014","journal-title":"Psychooncology"},{"key":"2026021806304639900_ljaf439-B24","first-page":"213","article-title":"Die deutsche version des NCCN Distress-Thermometers: empirische pr\u00fcfung eines screening-instruments zur erfassung psychosozialer belastung bei krebspatienten","volume":"54","author":"Mehnert-Theuerkauf","year":"2006","journal-title":"Z Psychiatr Psych Ps"},{"key":"2026021806304639900_ljaf439-B25","doi-asserted-by":"crossref","first-page":"3","DOI":"10.6004\/jnccn.2007.0003","article-title":"The NCCN guideline for distress management: a case for making distress the sixth vital sign","volume":"5","author":"Holland","year":"2007","journal-title":"J Natl Compr Canc Netw"},{"key":"2026021806304639900_ljaf439-B26","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1002\/(SICI)1097-0142(19980515)82:10<1904::AID-CNCR13>3.0.CO;2-X","article-title":"Rapid screening for psychologic distress in men with prostate carcinoma: a pilot study","volume":"82","author":"Roth","year":"1998","journal-title":"Cancer"},{"key":"2026021806304639900_ljaf439-B27","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/pon.1917","article-title":"Accuracy of the Danish version of the \u2018distress thermometer\u2019","volume":"21","author":"Bidstrup","year":"2012","journal-title":"Psychooncology"},{"key":"2026021806304639900_ljaf439-B28","author":"SGPO SSPO"},{"key":"2026021806304639900_ljaf439-B29","author":"Leitlinienprogramm Onkologie"},{"key":"2026021806304639900_ljaf439-B30","doi-asserted-by":"crossref","first-page":"e381","DOI":"10.1111\/aos.14277","article-title":"The national comprehensive cancer network distress thermometer as a screening tool for the evaluation of quality of life in uveal melanoma patients","volume":"98","author":"Klingenstein","year":"2020","journal-title":"Acta Ophthalmol"},{"key":"2026021806304639900_ljaf439-B31","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/pon.1976","article-title":"The nature and structure of psychological distress in people at high risk for melanoma: a factor analytic study","volume":"21","author":"Kasparian","year":"2012","journal-title":"Psychooncology"},{"key":"2026021806304639900_ljaf439-B32","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.3390\/cancers14153829","article-title":"Over-detection of melanoma-suspect lesions by a CE-certified smartphone app: performance in comparison to dermatologists, 2D and 3D convolutional neural networks in a prospective data set of 1204 pigmented skin lesions involving patients\u2019 perception","volume":"14","author":"Jahn","year":"2022","journal-title":"Cancers (Basel)"},{"key":"2026021806304639900_ljaf439-B33","doi-asserted-by":"crossref","first-page":"112954","DOI":"10.1016\/j.ejca.2023.112954","article-title":"Diagnostic performance of augmented intelligence with 2D and 3D total body photography and convolutional neural networks in a high-risk population for melanoma under real-world conditions: a new era of skin cancer screening?","volume":"190","author":"Cerminara","year":"2023","journal-title":"Eur J Cancer"},{"key":"2026021806304639900_ljaf439-B34","doi-asserted-by":"crossref","first-page":"1174542","DOI":"10.3389\/fonc.2023.1174542","article-title":"Educational level-dependent melanoma awareness in a high-risk population in Switzerland","volume":"13","author":"Mueller","year":"2023","journal-title":"Front Oncol"},{"key":"2026021806304639900_ljaf439-B35","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1111\/jdv.19905","article-title":"Patient and dermatologists\u2019 perspectives on augmented intelligence for melanoma screening: a prospective study","volume":"38","author":"Goessinger","year":"2024","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2026021806304639900_ljaf439-B36","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1111\/jdv.19777","article-title":"Consistency of convolutional neural networks in dermoscopic melanoma recognition: a prospective real-world study about the pitfalls of augmented intelligence","volume":"38","author":"Goessinger","year":"2024","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2026021806304639900_ljaf439-B37","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1037\/0278-6133.18.5.532","article-title":"Specific worry about breast cancer predicts mammography use in women at risk for breast and ovarian cancer","volume":"18","author":"Diefenbach","year":"1999","journal-title":"Heal Psychol"},{"key":"2026021806304639900_ljaf439-B38","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1136\/bmjebm-2023-112460","article-title":"Ecological study estimating melanoma overdiagnosis in the USA using the lifetime risk method","volume":"29","author":"Adamson","year":"2024","journal-title":"BMJ Evid Based Med"},{"key":"2026021806304639900_ljaf439-B39","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1054\/bjoc.2000.1545","article-title":"How successful are oncologists in identifying patient distress, perceived social support, and need for psychosocial counselling?","volume":"84","author":"S\u00f6llner","year":"2001","journal-title":"Br J Cancer"},{"key":"2026021806304639900_ljaf439-B40","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1054\/bjoc.2001.1724","article-title":"Psychiatric morbidity and its recognition by doctors in patients with cancer","volume":"84","author":"Fallowfield","year":"2001","journal-title":"Br J Cancer"},{"key":"2026021806304639900_ljaf439-B41","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1002\/pon.1975","article-title":"Patient versus clinician symptom reporting: how accurate is the detection of distress in the oncologic after-care?","volume":"21","author":"Werner","year":"2012","journal-title":"Psychooncology"},{"key":"2026021806304639900_ljaf439-B42","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/pon.4948","article-title":"Oncologist recommendation matters!\u00a0\u2013 \u200cPredictors of psycho-oncological service uptake in oncology outpatients","volume":"28","author":"Frey Nascimento","year":"2019","journal-title":"Psychooncology"},{"key":"2026021806304639900_ljaf439-B43","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/pon.3729","article-title":"Why do oncology outpatients who report emotional distress decline help?","volume":"24","author":"Clover","year":"2015","journal-title":"Psychooncology"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bjd\/advance-article-pdf\/doi\/10.1093\/bjd\/ljaf439\/65220845\/ljaf439.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/194\/3\/499\/65220845\/ljaf439.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/194\/3\/499\/65220845\/ljaf439.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T11:30:56Z","timestamp":1771414256000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/194\/3\/499\/8314647"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,5]]},"references-count":43,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,11,5]]},"published-print":{"date-parts":[[2026,2,18]]}},"URL":"https:\/\/doi.org\/10.1093\/bjd\/ljaf439","relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,3]]},"published":{"date-parts":[[2025,11,5]]}}}